Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Oragenics, Inc. (OGEN) had Stock-Based Compensation of $-0.06M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.27M |
|
-- |
|
-- |
|
$1.71M |
|
$-1.71M |
|
$-0.56M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
$-1.71M |
|
$-1.14M |
|
0.73M |
|
0.73M |
|
$-3.10 |
|
$-3.10 |
|
| Balance Sheet Financials | |
$2.14M |
|
-- |
|
-- |
|
$2.14M |
|
$4.27M |
|
-- |
|
-- |
|
$4.27M |
|
$-2.13M |
|
$-2.13M |
|
$-2.13M |
|
0.82M |
|
| Cash Flow Statement Financials | |
$-3.43M |
|
-- |
|
$4.54M |
|
$0.86M |
|
$1.97M |
|
$1.11M |
|
|
Stock-Based Compensation |
$-0.06M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.50 |
|
-- |
|
-- |
|
-- |
|
-1.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
106.78% |
|
106.78% |
|
-106.18% |
|
106.78% |
|
$-2.59 |
|
$-4.68 |
|
$-4.68 |
|